MEGAN DOWNEY: Open Payments
NPI 1972699486 · SPRINGFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,167 in 46 payments from 16 companies in 2025. Trend: 2023 $248 · 2024 $171 · 2025 $1,167
Food & beverage: $1,167
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 5 | $213 |
| Novo Nordisk Inc | 7 | $162 |
| Novartis Pharmaceuticals Corporation | 5 | $126 |
| PFIZER INC. | 5 | $112 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $101 |
| Actelion Pharmaceuticals US, Inc. | 3 | $80 |
| Alnylam Pharmaceuticals Inc. | 3 | $74 |
| SCPHARMACEUTICALS INC. | 1 | $60 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| Lilly USA, LLC | 2 | $42 |
Products named: CARDIOMEMS, Wegovy, VYNDAQEL, LEQVIO, JARDIANCE, OPSYNVI, FUROSCIX, ONPATTRO.
Industry payments across MA — which companies pay providers there.
